Position of SEAIC Concerning the Regulatory Process of Allergen-Based Medicines: A Compromise Between Quality and Availability for Allergic Patients in Spain
Por:
González-Mancebo, E, Miranda, EE, Purroy, A, González-de-Olano, D and Reig, AR
Publicada:
1 ene 2025
Ahead of Print:
14 oct 2025
Resumen:
Filiaciones:
González-Mancebo, E:
Hosp Univ Fuenlabrada, Allergy Unit, Madrid, Spain
Miranda, EE:
Univ Jaime 1, Hosp Gen Univ Castellon, Allergy Dept, Doctoral Sch, Castellon De La Plana, Spain
Purroy, A:
Hosp Univ Navarra HUNa, Pamplona, Spain
González-de-Olano, D:
Hosp Univ Ramon Y Cajal, Allergy Dept, IRYCIS, Madrid, Spain
:
HU Germans Trias, Immunotherapy Unit, Allergy Sect, Badalona, Barcelona, Spain
gold
|